Surrozen, Inc. (SRZN) Financials
SRZN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 120.7 million | 398.9 million |
| Dec. 31, 2025 | 98.7 million | 286.5 million |
| Sept. 30, 2025 | 94.0 million | 117.6 million |
| June 30, 2025 | 102.7 million | 55.6 million |
SRZN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -12.6 million | 2.1 million |
| Dec. 31, 2025 | -5.9 million | 1.0 million |
| Sept. 30, 2025 | -9.1 million | 1.0 million |
| June 30, 2025 | -6.1 million | 994000 |
SRZN Net Income
No data available :(
SRZN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 106.9 million | 4.9 million | - |
| Dec. 31, 2025 | 89.2 million | 5.3 million | 6.6 million |
| Sept. 30, 2025 | 81.3 million | - | 7.1 million |
| June 30, 2025 | 90.4 million | - | 7.5 million |
SRZN Shares Outstanding
SRZN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 120000 | 9.3 million | 6.1 million | - |
| Dec. 31, 2025 | 59000 | 9.0 million | 4.2 million | - |
| Sept. 30, 2025 | 24000 | 7.8 million | 4.1 million | - |
| June 30, 2025 | 18000 | 6.0 million | 4.0 million | - |
SRZN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 5.0 million | 65000 |
| Dec. 31, 2025 | 528000 | 45000 |
| Sept. 30, 2025 | 983000 | - |
| June 30, 2025 | 983000 | 137000 |
SRZN
Price: $22.06
52 week price:
Earnings Per Share: -36.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 41336
Market Capitalization: 348.1 million